Fred Alger Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

A detailed history of Fred Alger Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 536,298 shares of RARE stock, worth $22.6 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
536,298
Previous 548,905 2.3%
Holding current value
$22.6 Million
Previous $22.6 Million 32.06%
% of portfolio
0.15%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$40.21 - $59.36 $506,927 - $748,351
-12,607 Reduced 2.3%
536,298 $29.8 Million
Q2 2024

Aug 14, 2024
SELL
$37.42 - $51.61 $1.22 Million - $1.68 Million
-32,646 Reduced 5.61%
548,905 $22.6 Million
Q1 2024

May 15, 2024
SELL
$43.02 - $53.69 $964,723 - $1.2 Million
-22,425 Reduced 3.71%
581,551 $27.2 Million
Q4 2023

Feb 14, 2024
SELL
$31.73 - $49.19 $1.11 Million - $1.72 Million
-34,890 Reduced 5.46%
603,976 $28.9 Million
Q3 2023

Nov 14, 2023
SELL
$34.92 - $46.66 $601,985 - $804,371
-17,239 Reduced 2.63%
638,866 $22.8 Million
Q2 2023

Aug 14, 2023
BUY
$37.35 - $52.15 $4.2 Million - $5.87 Million
112,553 Added 20.71%
656,105 $30.3 Million
Q1 2023

May 15, 2023
BUY
$36.99 - $48.71 $1.78 Million - $2.34 Million
48,012 Added 9.69%
543,552 $21.8 Million
Q4 2022

Feb 14, 2023
BUY
$33.72 - $46.33 $4.38 Million - $6.01 Million
129,827 Added 35.5%
495,540 $23 Million
Q3 2022

Nov 14, 2022
BUY
$39.96 - $66.14 $4.14 Million - $6.85 Million
103,512 Added 39.48%
365,713 $15.1 Million
Q2 2022

Aug 15, 2022
SELL
$45.8 - $85.4 $804,797 - $1.5 Million
-17,572 Reduced 6.28%
262,201 $15.6 Million
Q1 2022

May 16, 2022
SELL
$62.2 - $84.4 $853,819 - $1.16 Million
-13,727 Reduced 4.68%
279,773 $20.3 Million
Q4 2021

Feb 14, 2022
BUY
$73.71 - $87.86 $189,950 - $226,415
2,577 Added 0.89%
293,500 $24.7 Million
Q3 2021

Nov 15, 2021
BUY
$77.92 - $102.4 $7.75 Million - $10.2 Million
99,491 Added 51.97%
290,923 $26.2 Million
Q2 2021

Aug 16, 2021
BUY
$92.19 - $115.71 $1.56 Million - $1.95 Million
16,868 Added 9.66%
191,432 $18.3 Million
Q1 2021

May 17, 2021
SELL
$106.9 - $167.73 $1.57 Million - $2.47 Million
-14,709 Reduced 7.77%
174,564 $19.9 Million
Q4 2020

Feb 16, 2021
SELL
$84.4 - $177.39 $5.98 Million - $12.6 Million
-70,809 Reduced 27.23%
189,273 $26.2 Million
Q3 2020

Nov 13, 2020
BUY
$72.98 - $90.0 $3.92 Million - $4.84 Million
53,761 Added 26.06%
260,082 $21.4 Million
Q2 2020

Aug 14, 2020
SELL
$46.91 - $78.22 $2.98 Million - $4.97 Million
-63,562 Reduced 23.55%
206,321 $16.1 Million
Q1 2020

May 15, 2020
BUY
$33.8 - $62.9 $4.8 Million - $8.93 Million
141,974 Added 111.0%
269,883 $12 Million
Q4 2019

Feb 14, 2020
BUY
$36.08 - $45.83 $275,831 - $350,370
7,645 Added 6.36%
127,909 $5.46 Million
Q3 2019

Nov 14, 2019
SELL
$42.5 - $63.11 $99,450 - $147,677
-2,340 Reduced 1.91%
120,264 $5.15 Million
Q2 2019

Aug 14, 2019
SELL
$54.93 - $74.36 $3.04 Million - $4.12 Million
-55,404 Reduced 31.12%
122,604 $7.79 Million
Q1 2019

May 14, 2019
SELL
$39.87 - $69.36 $857,484 - $1.49 Million
-21,507 Reduced 10.78%
178,008 $12.3 Million
Q4 2018

Feb 14, 2019
SELL
$38.89 - $77.3 $824,701 - $1.64 Million
-21,206 Reduced 9.61%
199,515 $8.68 Million
Q3 2018

Nov 14, 2018
SELL
$71.81 - $90.15 $947,461 - $1.19 Million
-13,194 Reduced 5.64%
220,721 $16.9 Million
Q2 2018

Jul 19, 2018
SELL
$48.54 - $85.31 $5.11 Million - $8.99 Million
-105,330 Reduced 31.05%
233,915 $18 Million
Q1 2018

May 10, 2018
SELL
$44.33 - $58.52 $2.22 Million - $2.93 Million
-49,991 Reduced 12.84%
339,245 $17.3 Million
Q4 2017

Feb 14, 2018
BUY
$43.54 - $57.32 $965,194 - $1.27 Million
22,168 Added 6.04%
389,236 $18.1 Million
Q3 2017

Nov 14, 2017
BUY
$49.79 - $66.32 $18.3 Million - $24.3 Million
367,068
367,068 $19.6 Million

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.6M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.95B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email